Profound Medical Corp

Company Profile

Profound Medical Corp had its IPO on 2016-06-09 under the ticker symbol PROF.

The company operates in the Healthcare sector and Medical Devices industry. Profound Medical Corp has a staff strength of 131 employees.

Stock update

Shares of Profound Medical Corp opened at $8.97 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $8.59 - $9.18, and closed at $8.59.

This is a -5.08% slip from the previous day's closing price.

A total volume of 12,134 shares were traded at the close of the day’s session.

In the last one week, shares of Profound Medical Corp have slipped by -4.98%.

Profound Medical Corp's Key Ratios

Profound Medical Corp has a market cap of $197.48 million, indicating a price to book ratio of 2.4719 and a price to sales ratio of 28.6712.

In the last 12-months Profound Medical Corp’s revenue was $6.75 million with a gross profit of $3.02 million and an EBITDA of $-27526000. The EBITDA ratio measures Profound Medical Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Profound Medical Corp’s operating margin was -411.7% while its return on assets stood at -26.77% with a return of equity of -51%.

In Q2, Profound Medical Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 20.9%.

Profound Medical Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.35 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Profound Medical Corp’s profitability.

Profound Medical Corp stock is trading at a EV to sales ratio of 13.7245 and a EV to EBITDA ratio of -3.2211. Its price to sales ratio in the trailing 12-months stood at 28.6712.

Profound Medical Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$56.81 million

Total Liabilities

$10.98 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Profound Medical Corp ended 2024 with $56.81 million in total assets and $0 in total liabilities. Its intangible assets were valued at $56.81 million while shareholder equity stood at $44.37 million.

Profound Medical Corp ended 2024 with $0 in deferred long-term liabilities, $10.98 million in other current liabilities, 216092000.00 in common stock, $-203458000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $39.28 million and cash and short-term investments were $39.28 million. The company’s total short-term debt was $7,581,000 while long-term debt stood at $0.

Profound Medical Corp’s total current assets stands at $54.69 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $6.59 million compared to accounts payable of $2.42 million and inventory worth $8.06 million.

In 2024, Profound Medical Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Profound Medical Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$8.59

52-Week High

$15.49

52-Week Low

$3.1

Analyst Target Price

$16.82

Profound Medical Corp stock is currently trading at $8.59 per share. It touched a 52-week high of $15.49 and a 52-week low of $15.49. Analysts tracking the stock have a 12-month average target price of $16.82.

Its 50-day moving average was $10.61 and 200-day moving average was $11.04 The short ratio stood at 13.13 indicating a short percent outstanding of 0%.

Around 441.5% of the company’s stock are held by insiders while 4098.2% are held by institutions.